Camelot Portfolios, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
Camelot Portfolios, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q4 2018$716,000
-3.6%
18,726
+1.3%
0.33%
-0.3%
Q3 2018$743,000
-1.8%
18,490
-1.5%
0.34%
+3.7%
Q2 2018$757,000
-5.5%
18,781
+132.1%
0.32%
-13.6%
Q1 2018$801,000
+8.7%
8,093
-61.1%
0.37%
+7.5%
Q4 2017$737,000
-13.9%
20,791
-1.4%
0.35%
-15.9%
Q3 2017$856,000
-3.3%
21,081
+2.8%
0.41%
-5.5%
Q2 2017$885,000
+1.0%
20,514
-1.3%
0.44%
+2.6%
Q1 2017$876,000
+10.1%
20,786
+0.6%
0.43%
+2.6%
Q4 2016$796,000
-38.4%
20,666
-31.0%
0.42%
-40.1%
Q3 2016$1,292,000
-0.4%
29,949
+0.1%
0.69%
-8.2%
Q2 2016$1,297,000
+6.4%
29,920
-0.4%
0.76%
+1.1%
Q1 2016$1,219,000
+4.3%
30,051
+3.7%
0.75%
+0.5%
Q4 2015$1,169,000
+30.2%
28,979
+24.1%
0.74%
+23.4%
Q3 2015$898,000
+5.8%
23,353
+14.6%
0.60%
+23.1%
Q2 2015$849,000
-3.6%
20,386
+6.8%
0.49%
-4.5%
Q1 2015$881,00019,0930.51%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2016
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 7,951,626$318,224,00010.49%
Healthcare Value Capital, LLC 120,000$4,802,0009.01%
KAHN BROTHERS GROUP INC 1,605,014$64,232,661,0008.03%
Eversept Partners, LP 693,685$28,091,8907.87%
EQUITY INVESTMENT CORP 2,673,764$107,004,0003.74%
Sio Capital Management, LLC 379,500$15,188,0003.66%
Martin Capital Partners, LLC 115,448$4,620,0003.27%
Circle Road Advisors LP 53,028$2,122,0003.10%
Keystone Financial Planning, Inc. 156,968$6,282,0003.07%
CAMG Solamere Management, LLC 160,294$6,415,0002.94%
View complete list of GLAXOSMITHKLINE PLC shareholders